In-vitro cellular study

Nicotinamide mononucleotide (NMN) protects bEnd.3 cells against H2O2-induced damage via NAMPT and the NF-κB p65 signalling pathway

Xiujun Deng et al. · FEBS Open Bio · 2021

Evidence type: Cellular and structural study Interpretive weight: Mechanistic contextResearch area: Cerebrovascular endothelial oxidative stress
DesignIn-vitro mechanistic study using mouse brain microvascular endothelial bEnd.3 cells exposed to hydrogen peroxide with graded NMN pretreatment and gene/protein, oxidative-stress, apoptosis, and endothelial-function assays.
PopulationMouse bEnd.3 brain microvascular endothelial cells in culture; no animal or human participants.
SampleMultiple independent cell-culture experiments with replicate assays; the publication reports three independent experiments for key molecular measurements.
InterventionbEnd.3 cells were exposed to hydrogen peroxide oxidative stress and pretreated with NMN across approximately 50–500 μM; 300 μM NMN was used for many mechanistic experiments.
EndpointsCell viability and cytotoxicity; Reactive oxygen species and antioxidant activity; Mitochondrial membrane potential; Apoptosis and caspase-3 activity; NAMPT, eNOS, and VEGF expression; NF-κB p65, IL-1β, TNF-α, ICAM-1, and MMP9 expression

What the publication reported

This cell-culture study tested whether NMN could protect mouse brain microvascular endothelial cells from hydrogen-peroxide-induced oxidative damage.

NMN pretreatment improved cell viability in several tested concentrations, reduced oxidative-stress and apoptosis-related measures, preserved mitochondrial membrane potential, and lowered inflammatory signaling.

The authors also reported higher NAMPT, eNOS, and VEGF expression and lower NF-κB p65, IL-1β, TNF-α, ICAM-1, and MMP9 after NMN under oxidative-stress conditions. These are cell-model findings and do not establish cerebrovascular benefit in people.

Key findings

  • Hydrogen peroxide reduced bEnd.3 cell viability, while NMN pretreatment improved viability across several concentrations.
  • NMN reduced oxidative-stress and apoptosis-related measures and lowered caspase-3 activity.
  • Mitochondrial membrane potential was better preserved with NMN treatment.
  • NMN increased NAMPT, eNOS, and VEGF expression in key experiments.
  • NF-κB p65 and inflammatory mediators including IL-1β, TNF-α, ICAM-1, and MMP9 were reduced with NMN.
  • The authors interpreted NAMPT upregulation and NF-κB p65 inhibition as part of the protective mechanism.

What it cannot establish

  • The study used an immortalized mouse endothelial cell line rather than intact brain vessels or human participants.
  • Hydrogen peroxide exposure is a simplified oxidative-stress model and does not reproduce complex cerebrovascular disease.
  • Micromolar cell-culture NMN concentrations cannot be translated directly into oral human doses.
  • The study did not measure clinical cerebrovascular, cognitive, or blood-brain-barrier outcomes.
  • Cell survival and signaling changes do not establish benefit in vivo.
HealthspanX claim boundary: This study does not establish that NMN protects the blood-brain barrier, prevents stroke, improves cognition, or produces cerebrovascular benefit in humans.

Continue reviewing

Return to the complete evidence library.

Evidence Center Ultra Pure NMN

Source fields verified